Literature DB >> 2406595

Isolate-dependent differences in the oxidative metabolism of Trypanosoma cruzi epimastigotes.

J C Engel1, P S Doyle, J A Dvorak.   

Abstract

Epimastigote cultures of the two cloned Trypanosoma cruzi stocks, CA-I/72 and HO-3/15, grown under identical conditions, differ both qualitatively and quantitatively in their cytochrome content. The CA-I/72 stock has a four-fold higher cytochrome b content (19.2 nM (mg protein)-1) than the HO-3/15 stock (4.9 nM (mg protein)-1). Cytochrome o is present at 29 nM (mg protein)-1 in the CA-I/72 stock but is below detectable limits in the HO-3/15 stock. There is no inter-stock difference in oxygen utilization (12-15 nM O2 min-1 (mg protein)-1) during exponential growth. However, stationary phase CA-I/72 epimastigotes utilize twice as much oxygen as HO-3/15 epimastigotes. Oxygen utilization by HO-3/15 epimastigotes incubated in Dulbecco's phosphate buffer solution (starvation conditions), was stimulated earlier and to higher levels by the addition of glucose than by CA-I/72 epimastigotes under identical conditions. Under starvation conditions and with the cytochrome chain partially inhibited by antimycin A,(anti-A) the addition addition of glucose also increased oxygen utilization by CA-I/72 epimastigotes. In contrast, anti-A did not influence glucose-stimulated oxygen utilization by HO-3/15 epimastigotes. Following partial inhibition with anti-A, salicylhydroxamic acid produced an additional 50% inhibition in oxygen utilization in both stocks irrespective of the growth phase of the organisms. These data indicate that marked intra-specific differences in oxidative metabolism exist within the T. cruzi population and that an alpha-glycerophosphate oxidase or similar salicylhydroxamic acid-inhibitable compound may be present in the organism.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2406595     DOI: 10.1016/0166-6851(90)90009-b

Source DB:  PubMed          Journal:  Mol Biochem Parasitol        ISSN: 0166-6851            Impact factor:   1.759


  4 in total

1.  Two approaches to discovering and developing new drugs for Chagas disease.

Authors:  J H McKerrow; P S Doyle; J C Engel; L M Podust; S A Robertson; R Ferreira; T Saxton; M Arkin; I D Kerr; L S Brinen; C S Craik
Journal:  Mem Inst Oswaldo Cruz       Date:  2009-07       Impact factor: 2.743

2.  O2 consumption rates along the growth curve: new insights into Trypanosoma cruzi mitochondrial respiratory chain.

Authors:  Thiago M Silva; Eduardo F Peloso; Simone C Vitor; Luis H G Ribeiro; Fernanda R Gadelha
Journal:  J Bioenerg Biomembr       Date:  2011-07-06       Impact factor: 2.945

3.  Shotgun sequencing analysis of Trypanosoma cruzi I Sylvio X10/1 and comparison with T. cruzi VI CL Brener.

Authors:  Oscar Franzén; Stephen Ochaya; Ellen Sherwood; Michael D Lewis; Martin S Llewellyn; Michael A Miles; Björn Andersson
Journal:  PLoS Negl Trop Dis       Date:  2011-03-08

4.  Gene expression to mitochondrial metabolism: Variability among cultured Trypanosoma cruzi strains.

Authors:  Murat C Kalem; Evgeny S Gerasimov; Pamela K Vu; Sara L Zimmer
Journal:  PLoS One       Date:  2018-05-30       Impact factor: 3.240

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.